These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17012905)

  • 1. Comparison of rabbit and mouse models for persistence analysis of plasmid-based vaccines.
    Leamy VL; Martin T; Mahajan R; Vilalta A; Rusalov D; Hartikka J; Bozoukova V; Hall KD; Morrow J; Rolland AP; Kaslow DC; Lalor PA
    Hum Vaccin; 2006; 2(3):113-8. PubMed ID: 17012905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. I. Poloxamer-formulated plasmid DNA-based human cytomegalovirus vaccine: evaluation of plasmid DNA biodistribution/persistence and integration.
    Vilalta A; Mahajan RK; Hartikka J; Rusalov D; Martin T; Bozoukova V; Leamy V; Hall K; Lalor P; Rolland A; Kaslow DC
    Hum Gene Ther; 2005 Oct; 16(10):1143-50. PubMed ID: 16218775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. II. Cationic lipid-formulated plasmid DNA-based Bacillus anthracis vaccine: evaluation of plasmid DNA persistence and integration potential.
    Vilalta A; Mahajan RK; Hartikka J; Leamy V; Martin T; Rusalov D; Bozoukova V; Lalor P; Hall K; Kaslow DC; Rolland A
    Hum Gene Ther; 2005 Oct; 16(10):1151-6. PubMed ID: 16218776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid DNA malaria vaccine: tissue distribution and safety studies in mice and rabbits.
    Parker SE; Borellini F; Wenk ML; Hobart P; Hoffman SL; Hedstrom R; Le T; Norman JA
    Hum Gene Ther; 1999 Mar; 10(5):741-58. PubMed ID: 10210142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonclinical biodistribution, integration, and toxicology evaluations of an H5N1 pandemic influenza plasmid DNA vaccine formulated with Vaxfectin®.
    Doukas J; Morrow J; Bellinger D; Hilgert T; Martin T; Jones D; Mahajan R; Rusalov D; Sullivan S; Rolland A
    Vaccine; 2011 Jul; 29(33):5443-52. PubMed ID: 21641955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo kinetics and biodistribution of a HIV-1 DNA vaccine after administration in mice.
    Kim BM; Lee DS; Choi JH; Kim CY; Son M; Suh YS; Baek KH; Park KS; Sung YC; Kim WB
    Arch Pharm Res; 2003 Jun; 26(6):493-8. PubMed ID: 12877561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice.
    Dupuis M; Denis-Mize K; Woo C; Goldbeck C; Selby MJ; Chen M; Otten GR; Ulmer JB; Donnelly JJ; Ott G; McDonald DM
    J Immunol; 2000 Sep; 165(5):2850-8. PubMed ID: 10946318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction of a dual-promoter DNA expression plasmid pCN-SSIE harboring gene encoding SBR of Streptococcus mutans and verification of its immunogenicity as DNA vaccine].
    Liu H; Jiang GS; Bian JF; Liu XX; Sun JJ; Wang XH
    Shanghai Kou Qiang Yi Xue; 2005 Oct; 14(5):479-84. PubMed ID: 16288326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution and general safety of a naked DNA plasmid, GTU-MultiHIV, in a rat, using a quantitative PCR method.
    Tuomela M; Malm M; Wallen M; Stanescu I; Krohn K; Peterson P
    Vaccine; 2005 Jan; 23(7):890-6. PubMed ID: 15603889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model.
    Li L; Li S; Zhou Y; Yang L; Zhou D; Yang Y; Lu M; Yang D; Song J
    Virol J; 2017 Oct; 14(1):205. PubMed ID: 29070073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice.
    Merdan T; Kunath K; Petersen H; Bakowsky U; Voigt KH; Kopecek J; Kissel T
    Bioconjug Chem; 2005; 16(4):785-92. PubMed ID: 16029019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The doses of plasmid backbone plays a major role in determining the HBV clearance in hydrodynamic injection mouse model.
    Wang X; Zhu J; Zhang Y; Li Y; Ma T; Li Q; Xu J; Xu L
    Virol J; 2018 May; 15(1):89. PubMed ID: 29783985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine.
    Parker SE; Monteith D; Horton H; Hof R; Hernandez P; Vilalta A; Hartikka J; Hobart P; Bentley CE; Chang A; Hedstrom R; Rogers WO; Kumar S; Hoffman SL; Norman JA
    Gene Ther; 2001 Jul; 8(13):1011-23. PubMed ID: 11438836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the persistence, integration, histopathology and environmental release of DNA vaccine encoding Eimeria tenella TA4 and chicken IL-2.
    Song X; Zhang Z; Liu C; Xu L; Yan R; Li X
    Vet Parasitol; 2016 Oct; 229():22-30. PubMed ID: 27809974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid DNA vaccines: assay for integration into host genomic DNA.
    Ledwith BJ; Manam S; Troilo PJ; Barnum AB; Pauley CJ; Griffiths TG; Harper LB; Schock HB; Zhang H; Faris JE; Way PA; Beare CM; Bagdon WJ; Nichols WW
    Dev Biol (Basel); 2000; 104():33-43. PubMed ID: 11713822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection.
    Martin T; Parker SE; Hedstrom R; Le T; Hoffman SL; Norman J; Hobart P; Lew D
    Hum Gene Ther; 1999 Mar; 10(5):759-68. PubMed ID: 10210143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical safety and biodistribution of Sindbis virus measles DNA vaccines administered as a single dose or followed by live attenuated measles vaccine in a heterologous prime-boost regimen.
    Ramirez K; Barry EM; Ulmer J; Stout R; Szabo J; Manetz S; Levine MM; Pasetti MF
    Hum Gene Ther; 2008 May; 19(5):522-31. PubMed ID: 18507515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copy number variability of expression plasmids determined by cell sorting and Droplet Digital PCR.
    Jahn M; Vorpahl C; Hübschmann T; Harms H; Müller S
    Microb Cell Fact; 2016 Dec; 15(1):211. PubMed ID: 27993152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation.
    Dolter KE; Evans CF; Ellefsen B; Song J; Boente-Carrera M; Vittorino R; Rosenberg TJ; Hannaman D; Vasan S
    Vaccine; 2011 Jan; 29(4):795-803. PubMed ID: 21094270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution and safety studies of hDel-1 plasmid-based gene therapy in mouse and rabbit models.
    Quezada A; Larson J; French M; Ponce R; Perrard J; Durland R; Coleman M
    J Pharm Pharmacol; 2004 Feb; 56(2):177-85. PubMed ID: 15005876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.